NIH-funded research R01 grant

Investigating the link between iron levels and symptoms in psychotic disorders

Official title: Iron deficits and their relationship with symptoms and cognition in Psychotic Spectrum Disorders

Funded at New York University School of Medicine · NIH-11010817 · Data updated 2026-11-12

This study is looking at how low iron levels might influence symptoms and thinking skills in people with psychotic spectrum disorders, and it involves using brain scans to see how iron in the brain relates to these issues in both teens and adults.

More Cognition research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$609,521
NIH project number5R01MH129934-03
Project IDNIH-11010817 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with psychotic spectrum disorders, particularly those experiencing cognitive challenges.

Less likely to help

Patients with psychotic disorders who do not have any iron metabolism issues or those who are not experiencing cognitive deficits may not benefit from this research.

What this research studies

This research explores how iron deficits may affect symptoms and cognitive abilities in individuals with psychotic spectrum disorders (PSD). By using advanced MRI techniques, the study aims to measure iron content in specific brain regions and determine its relationship with the severity of symptoms and cognitive function. The research focuses on various age groups, from adolescents to adults, to understand how iron metabolism impacts brain health and disorder progression. Participants may undergo brain imaging to assess iron levels and their potential effects on mental health.

Why it matters

Potential benefit: If successful, this research could lead to new treatment strategies that address cognitive deficits in patients with psychotic disorders by targeting iron metabolism.

How similar studies have gone: While the relationship between iron levels and cognitive function in psychotic disorders is an emerging area, previous studies have suggested potential links, indicating that this research could build on existing findings.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Lazar, Mariana — New York University School of Medicine
  • Study coordinator: Lazar, Mariana

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.